This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Isoproterenol Hydrochloride

Read time: 1 mins
Marketing start date: 12 Jul 2025
...
 

Summary of product characteristics


Effective Time

20230714

Version

1

Spl Product Data Elements

Isoproterenol Hydrochloride Isoproterenol Hydrochloride ISOPROTERENOL HYDROCHLORIDE ISOPROTERENOL ANHYDROUS CITRIC ACID EDETATE DISODIUM HYDROCHLORIC ACID SODIUM CHLORIDE SODIUM HYDROXIDE TRISODIUM CITRATE DIHYDRATE WATER Isoproterenol Hydrochloride Isoproterenol Hydrochloride ISOPROTERENOL HYDROCHLORIDE ISOPROTERENOL ANHYDROUS CITRIC ACID EDETATE DISODIUM HYDROCHLORIC ACID SODIUM CHLORIDE SODIUM HYDROXIDE TRISODIUM CITRATE DIHYDRATE WATER

Application Number

ANDA215557

Brand Name

Isoproterenol Hydrochloride

Generic Name

Isoproterenol Hydrochloride

Product Ndc

70771-1831

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1831-1 Isoproterenol Hydrochloride Injection USP, 0.2 mg/mL 1 mL Vial Rx only NDC 70771-1831-6 Isoproterenol Hydrochloride Injection USP, 0.2 mg/mL Carton of 10 x 1 mL Vial Rx only NDC 70771-1832-1 Isoproterenol Hydrochloride Injection USP, 1 mg/ 5 mL (0.2 mg/mL) 5 mL Vial Rx only NDC 70771-1832-6 Isoproterenol Hydrochloride Injection USP, 1 mg/ 5 mL (0.2 mg/mL) Carton of 10 x 5 mL Vial Rx only 0.2 mg/mL 0.2 mg/mL carton 1 mg/5 mL vial 1mg/5 mL carton

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.